Fundraising FoxBrainScope
Bethesda, US · Delaware corporation · 6 known investors
Find your way into BrainScope
Sign up to see every warm intro you have to BrainScope
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BrainScope team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BrainScope is a neurotechnology company that turns EEG brain electrical activity into objective diagnostic biomarkers using machine and deep learning for assessing head injuries, concussion, and other brain conditions. Its technology serves clinical settings such as emergency departments, outpatient clinics, and sports, and it is developing biomarkers for areas including early Alzheimer's detection, stroke, and military blast exposure.
Founders & leadership
Board
Investors · 6
How we know: the company's own site · funding news · biohealthinnovation.org · Not right? Tell us
How we know: funding news · biohealthinnovation.org · Not right? Tell us
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$35.4M disclosed across 3 of 4 rounds · 2010–2021
▶$16.4MraisedSep 2017 · 38 investors · Other Health CareRule 506(b)
- Miles GilburneDirector
- Cynthia RingoDirector
- James PeakeDirector
- Laurie SilverExecutive Officer
- Daniel MooreDirector
- Gail WilenskyDirector
- Jean CaseDirector
- Michael E. SingerExecutive Officer, Director
- John M. ReherDirector
- Andrew HolmanExecutive Officer
- Offering amount
- $16.4M
- Amount sold
- $16.4M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedSep 2015 · 12 investors · Other Health CareRule 506(b)
- Michael E. SingerExecutive Officer, Director
- Jean CaseDirector
- John M. ReherDirector
- Gail WilenskyDirector
- James PeakeDirector
- Kerstin SchultzExecutive Officer
- Laurie SilverExecutive Officer
- Daniel MooreDirector
- Miles GilburneDirector
- Offering amount
- $2.9M
- Amount sold
- $2.5M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.5MraisedSep 2015 · 43 investors · Other Health CareRule 506(b)
- Laurie SilverExecutive Officer
- James PeakeDirector
- Michael E. SingerExecutive Officer, Director
- Miles GilburneDirector
- Jean CaseDirector
- John M. ReherDirector
- Kerstin SchultzExecutive Officer
- Daniel MooreDirector
- Gail WilenskyDirector
- Offering amount
- $16.5M
- Amount sold
- $16.5M
- First sale
- Sep 2010
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does BrainScope do?
- BrainScope is a neurotechnology company that turns EEG brain electrical activity into objective diagnostic biomarkers using machine and deep learning for assessing head injuries, concussion, and other brain conditions. Its technology serves clinical settings such as emergency departments, outpatient clinics, and sports, and it is developing biomarkers for areas including early Alzheimer's detection, stroke, and military blast exposure.
- Who are BrainScope's investors?
- BrainScope's investors include DBL Partners, Revolution, Brain Trust Accelerator Fund.
- How much funding has BrainScope raised?
- BrainScope has disclosed $35.4M raised across 3 of its 4 known rounds.
- Where is BrainScope headquartered?
- BrainScope is headquartered in Bethesda, US.